EDGAR Filing Documents for 0001558370-22-002373

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-22-002373

Filing Date

2022-02-28

Accepted

2022-02-28 16:36:52

Documents

111

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	tbph-20211231x10k.htm iXBRL	10-K	3520075
2	EX-10.69	tbph-20211231xex10d69.htm	EX-10.69	49407
3	EX-10.70	tbph-20211231xex10d70.htm	EX-10.70	40084
4	EX-10.71	tbph-20211231xex10d71.htm	EX-10.71	74917
5	EX-10.72	tbph-20211231xex10d72.htm	EX-10.72	147828
6	EX-21.1	tbph-20211231xex21d1.htm	EX-21.1	3311
7	EX-23.1	tbph-20211231xex23d1.htm	EX-23.1	5993
8	EX-23.2	tbph-20211231xex23d2.htm	EX-23.2	2924
9	EX-31.1	tbph-20211231xex31d1.htm	EX-31.1	10464
10	EX-31.2	tbph-20211231xex31d2.htm	EX-31.2	10421
11	EX-32	tbph-20211231xex32.htm	EX-32	15334
12	GRAPHIC	tbph-20211231x10k006.jpg	GRAPHIC	82205
13	GRAPHIC	tbph-20211231x10k008.jpg	GRAPHIC	47192
14	GRAPHIC	tbph-20211231xex10d72001.jpg	GRAPHIC	56817
15	GRAPHIC	tbph-20211231xex10d72003.jpg	GRAPHIC	40776
16	GRAPHIC	tbph-20211231xex10d72002.jpg	GRAPHIC	47219
17	GRAPHIC	tbph-20211231xex10d72005.jpg	GRAPHIC	65079
	Complete submission text file	0001558370-22-002373.txt		14735676

Data Files

Seq	Description	Document	Type	Size
18	EX-101.SCH	tbph-20211231.xsd	EX-101.SCH	75207
19	EX-101.CAL	tbph-20211231_cal.xml	EX-101.CAL	79149
20	EX-101.DEF	tbph-20211231_def.xml	EX-101.DEF	374874
21	EX-101.LAB	tbph-20211231_lab.xml	EX-101.LAB	705756
22	EX-101.PRE	tbph-20211231_pre.xml	EX-101.PRE	587415
105	EXTRACTED XBRL INSTANCE DOCUMENT	tbph-20211231x10k_htm.xml	XML	2727636

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104

Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000

Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)